Drug Safety

Drug Safety

Patient safety is of paramount importance to Jazz Pharmaceuticals. It is our ethical and regulatory responsibility to monitor the safety of the medicines we develop from their preclinical stage through clinical testing and prescribing. Timely reporting to Drug Safety is critical to enable compliance with regulatory requirements.

If you are a patient reporting occurrence of adverse events or if you have questions about your condition, please contact your health care practitioner.

Reporting an Adverse Event or Product Complaint in the U.S.

To report an adverse event or a product complaint about our products, please call one of the product-specific telephone numbers listed below.

Defitelio®

(defibrotide sodium) injection
1-800-520-5568

Erwinaze®

(asparaginase Erwinia chrysanthemi) injection
1-800-520-5568

FazaClo®

(clozapine) orally disintegrating clozapine tablets
1-800-520-5568

Sunosi

(solriamfetol)
1-800-520-5568

Vyxeos®

(daunorubicin and cytarabine) liposome for injection
1-800-520-5568

Xyrem®

(sodium oxybate) oral solution
1-800-520-5568

Reporting an Adverse Event or Product Complaint in Europe and Rest of World

To report an adverse event or a product complaint for Defitelio®, Erwinase®, Kidrolase®, Vyxeos® or Xyrem® (Canada only), please call using one of the country-specific telephone numbers listed below.

For inquiries in:

Dutch

 
+31 207176898
For inquiries in:

English

 
Canada: +1 800 520 5568
UK/Ireland: +44 8450305089
For inquiries in:

French

 
+33 176728925
For inquiries in:

German

 
+49 3056796128
For inquiries in:

Italian

 
+39 0687500850
For inquiries in:

Polish

 
+48 221253377
For inquiries in:

Portuguese

 
+351 308805626
For inquiries in:

Spanish

 
+34 914142493
For other inquiries in:

EU/RoW

 
+44 8450305089